Evargraf 0.25 mg Tablet
$7,93
$5,11
Evargraf 0.25 mg Tablet is a targeted anticancer therapy designed to combat various advanced cancers, including those affecting the pancreas, stomach, intestines, and lungs that are not amenable to surgical intervention. This medication works by inhibiting the growth of cancer cells, thereby slowing down disease progression and potentially improving patient outcomes. It is crucial for patients to discuss their complete medical history with healthcare providers, as Evargraf may cause side effects and interacts with other medications. Regular monitoring is essential to manage any adverse reactions effectively. Patients should be aware of potential signs of infection, as the drug can affect immune function. Additionally, women who are pregnant or breastfeeding should avoid using Evargraf due to possible risks to the fetus or infant. As a part of a comprehensive cancer treatment plan, Evargraf can play a vital role in managing challenging cases, providing hope for those facing difficult diagnoses. Always consult a healthcare professional to ensure safe and effective use of this medication.
數量
Active Pharmaceutical Ingredient
Uses
• Evargraf 0 25 mg tablet is primarily utilized in the treatment of postmenopausal women diagnosed with advanced hormone receptor-positive, HER2-negative breast cancer. It is often prescribed in combination with exemestane, particularly after previous treatments with letrozole or anastrozole have failed. This medication helps manage the disease by targeting specific hormonal pathways, thus slowing the progression of cancer. Patients experiencing symptoms such as breast pain, changes in breast size, or unexplained weight loss may benefit from this therapy.
• Another significant use of Evargraf 0 25 mg tablet is in the management of neuroendocrine tumors (NET). These rare tumors can arise in various organs, including the lungs and pancreas, and often require specialized treatment approaches. By using Evargraf 0 25 mg tablet, healthcare providers aim to control tumor growth and improve patient outcomes. Its application in this context underscores the importance of targeted therapies in treating complex cancer cases.
• Evargraf 0 25 mg tablet is also indicated for adult patients with kidney cancer who have not responded adequately to prior treatments such as sunitinib or sorafenib. This medication can play a crucial role in the management of symptoms associated with kidney cancer, including fatigue and weight loss. By addressing the underlying disease mechanisms, Evargraf 0 25 mg tablet helps to prolong survival and enhance the quality of life for these patients.
• In the context of Tuberous Sclerosis Complex (TSC), Evargraf 0 25 mg tablet is used to treat renal angiomyolipomas in adult patients who do not require immediate surgical intervention. This application illustrates the versatility of Evargraf 0 25 mg tablet in managing tumor-related complications associated with genetic conditions. Additionally, it is effective in treating subependymal giant cell astrocytomas (SEGA) in both adult and pediatric patients aged one year and older. The use of Evargraf 0 25 mg tablet in these scenarios highlights its role in providing necessary therapeutic interventions for challenging tumor types.
Benefits
Evargraf 0.25 mg Tablet is indicated to patients dealing with various cancers such as breast cancer, pancreatic cancer, lung cancer, kidney cancer and stomach/ intestinal cancer. Cancer of this type tends to spread quickly in other parts of the body. Benefits of Evargraf 0.25 mg Tablet travels through the bloodstream and effectively destroys cancerous cells and other parts of the body. It works by decreasing the activity of the immune system of the body and prevents the rejection of the transplanted organ. Evargraf 0.25 mg works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. In this way, it stops the spread of cancerous cells. Besides this, it is also effective in people with genetic disorders to treat some types of tumours in the brain or kidneys.
Side Effects
How Evargraf 0.25 mg Tablet works may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Infection
• Urinary issues
• Hypertension, rise in cholesterol or triglycerides
• Stomach pain, nausea, diarrhoea and/or constipation
• Headache
• Swelling in your legs or feet
Common Side Effects
• Swelling in legs and feet
• Blood in stools and urine
• Burning sensation during urination
• Mouth sores
• Headache
• Tiredness
• Nausea
How To Use
Side effects of Evargraf 0.25 mg Tablet can be taken by mouth with or without food. Swallow the whole tablet with a glass of water. Do not crush, break, or chew the tablets. Take your dose around the same time every day. It is important to make sure you are taking the correct amount of medication every time. Before every dose, check that what you are taking matches what you have been prescribed. If you miss a dose and it has been less than 6 hours since your regular dose time, take it as soon as you remember. If it has been more than 6 hours, skip the dose. Do not take 2 doses at once to make up for a missed dose.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Side effects of Evargraf 0.25 mg Tablet. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Evargraf 0.25 mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Evargraf 0.25 mg is recommended.
• Breastfeeding: It is not recommended to breastfeed while taking Evargraf 0.25 mg. Uses of Evargraf 0.25 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Benefits of Evargraf 0.25 mg Tablet, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Benefits of Evargraf 0.25 mg Tablet should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Evargraf 0.25 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Evargraf 0.25 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Benefits of Evargraf 0.25 mg Tablet may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Uses of Evargraf 0.25 mg Tablet during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: How Evargraf 0.25 mg Tablet works may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this How Evargraf 0.25 mg Tablet works.